Elasmobranch immune cells as a source of novel tumor cell inhibitors: implications for public health.

dc.contributor.author	Walsh, Catherine J.
dc.contributor.author	Luer, Carl A.
dc.contributor.author	Bodine, A.B.
dc.contributor.author	Smith, Clayton A.
dc.contributor.author	Cox, Heather L.
dc.contributor.author	Noyes, David R.
dc.contributor.author	Gasparetto, Maura
dc.date.accessioned	2007-09-25T19:29:43Z
dc.date.available	2007-09-25T19:29:43Z
dc.date.issued	2007
dc.identifier.citation	Integrative and Comparative Biology 46(6).	en
dc.identifier.issn	0003-1569
dc.identifier.uri	http://hdl.handle.net/2075/194
dc.description	10 p.	en
dc.description.sponsorship	NIH, Elsa U. Parded Foundation, Ann and Alfred Goldstein Foundation, Vernal W. and Florence H. Bates Foundation, and the Polly Loomis Endowment.	en
dc.format.extent	334929 bytes
dc.format.mimetype	application/pdf
dc.language.iso	en_US	en
dc.publisher	Oxford University Press on behalf of the Society for Integrative and Comparative Biology.	en
dc.subject	immunology	en
dc.subject	shark immune systems	en
dc.subject	tumor cell lines	en
dc.subject	elasmobranchs	en
dc.subject	epigonal cells	en
dc.subject	cytokines	en
dc.subject	public health	en
dc.title	Elasmobranch immune cells as a source of novel tumor cell inhibitors: implications for public health.	en
dc.type	Article	en